These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Predictors of relapse rate in MS clinical trials. Held U, Heigenhauser L, Shang C, Kappos L, Polman C, Sylvia Lawry Centre for MS Research. Neurology; 2005 Dec 13; 65(11):1769-73. PubMed ID: 16344520 [Abstract] [Full Text] [Related]
7. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Thompson AJ, Kermode AG, Wicks D, MacManus DG, Kendall BE, Kingsley DP, McDonald WI. Ann Neurol; 1991 Jan 13; 29(1):53-62. PubMed ID: 1996879 [Abstract] [Full Text] [Related]
9. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, Giorgio A, Bartolozzi ML, Guidi L, Sorbi S, Federico A, Amato MP, De Stefano N. Neurology; 2009 Aug 18; 73(7):498-503. PubMed ID: 19641173 [Abstract] [Full Text] [Related]
10. Management of worsening multiple sclerosis with mitoxantrone: a review. Fox EJ. Clin Ther; 2006 Apr 18; 28(4):461-74. PubMed ID: 16750460 [Abstract] [Full Text] [Related]
11. The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA. Paolillo A, Piattella MC, Pantano P, Di Legge S, Caramia F, Russo P, Lenzi GL, Pozzilli C. J Neurol; 2004 Apr 18; 251(4):432-9. PubMed ID: 15083288 [Abstract] [Full Text] [Related]
14. Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis. Molyneux PD, Filippi M, Barkhof F, Gasperini C, Yousry TA, Truyen L, Lai HM, Rocca MA, Moseley IF, Miller DH. Ann Neurol; 1998 Mar 18; 43(3):332-9. PubMed ID: 9506550 [Abstract] [Full Text] [Related]
15. Short-term brain atrophy changes in relapsing-remitting multiple sclerosis. Zivadinov R, Bagnato F, Nasuelli D, Bastianello S, Bratina A, Locatelli L, Watts K, Finamore L, Grop A, Dwyer M, Catalan M, Clemenzi A, Millefiorini E, Bakshi R, Zorzon M. J Neurol Sci; 2004 Aug 30; 223(2):185-93. PubMed ID: 15337621 [Abstract] [Full Text] [Related]
19. Association between MRI parameters and the MS severity scale: a 12 year follow-up study. Minneboo A, Uitdehaag BM, Jongen P, Vrenken H, Knol Dl, van Walderveen MA, Polman CH, Castelijns JA, Barkhof F. Mult Scler; 2009 May 30; 15(5):632-7. PubMed ID: 19389751 [Abstract] [Full Text] [Related]
20. Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases. Gajofatto A, Monaco S, Fiorini M, Zanusso G, Vedovello M, Rossi F, Turatti M, Benedetti MD. Arch Neurol; 2010 Jun 30; 67(6):724-30. PubMed ID: 20558391 [Abstract] [Full Text] [Related] Page: [Next] [New Search]